Glow Lifetech Corp. (CNSX: GLOW)
Health Care · Pharmaceuticals · CA
CA$0.05
-10.00% today · -30.8% 1Y
Glow Lifetech Corp. (CNSX: GLOW) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.29M and employs 5 people.
Over the last twelve months the share price has lost 30.8%, trading between 0.04 and 0.08.
Tweenvest scores Glow Lifetech Corp. across four factors: quality 30/100, value 73/100. Its strongest factor is value.
GLOW price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.29M
- Revenue (TTM)
- $1.59M
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 1.47
- 52-week high
- CA$0.08
- 52-week low
- CA$0.04
- Avg volume (3M)
- —
- Shares outstanding
- 192.44M
- Employees
- 5
- Next earnings
- —
About Glow Lifetech Corp.
Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
- ISIN
- CA37989H1091
- Founded
- 1988
- Listed since
- Mar 15, 2021
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.